Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OTCMKTS:SPRCY

SciSparc (SPRCY) Stock Price, News & Analysis

About SciSparc Stock (OTCMKTS:SPRCY)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$3.99
$4.90
50-Day Range
$4.00
$4.00
52-Week Range
$2.75
$12.25
Volume
12,500 shs
Average Volume
10,035 shs
Market Capitalization
$4.15 million
P/E Ratio
0.27
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. SciSparc Ltd. has an agreement with Procaps to develop and commercially manufacture SCI-110, as well as CannAmide, a palmitoylethanolamide compound in softgel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to perform a pre-clinical study for the evaluation of SCI-210 drug development program for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv, Israel.

Remove Ads
Receive SPRCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SciSparc and its competitors with MarketBeat's FREE daily newsletter.

SPRCY Stock News Headlines

SciSparc: AutoMax announces $13M first delivery of JAC vehicles
SciSparc Announces Spin-Off Plans with Miza III Ventures
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Latest News for SciSparc Stock (NASDAQ:SPRC)
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:SPRCY
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
0.27
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$2.65 per share
Price / Cash Flow
1.51
Book Value
$1.38 per share
Price / Book
2.90

Miscellaneous

Free Float
N/A
Market Cap
$4.15 million
Optionable
Not Optionable
Beta
-0.08
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:SPRCY) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners